Abstract
The discovery of Helicobacter pylori (H. pylori), the curved or spiral shaped bacteria, as the main etiologic organism of chronic gastritis, peptic ulcer disease, and gastric cancer was one the most significant discoveries in gastroenterology of the twentieth century. Helicobacter infections promote infiltration of the gastric mucosa by neutrophils, macrophages, and T and B lymphocytes, and leaves the host prone to complications resulting from chronic inflammation. If left untreated, persistent gastrointestinal infections and chronic gastritis may evolve into more severe diseases, such as peptic ulcer or atrophic gastritis. In addition, infection with H. pylori increases the risk of developing gastric adenocarcinoma and mucosa-associated lymphoid tissue lymphoma. Helicobacter pylori infections are of great concern worldwide due to increasing antimicrobial resistance and high re-infection rates. In the 1990’s scientific evaluation of natural products and ethnomedicines for the treatment of H. pylori infections began in earnest, and many natural products have been investigated over the past 20 years with promising in vitro results. This review highlights these achievements and the classes of naturally occurring compounds with activity against H. pylori. It also points out the critical need of new treatments for H. pylori infections due to increasing global resistance.
Keywords: Helicobacter pylori, ethnomedicine, gastritis, natural products, peptic ulcer disease.
Current Bioactive Compounds
Title:Susceptibility of Helicobacter pylori to Natural Products: Can Past Research Direct Future Drug Development?
Volume: 8 Issue: 3
Author(s): Temitope O. Lawal, Kapil K. Soni, Brian J. Doyle, Bolanle A. Adeniyi and Gail B. Mahady
Affiliation:
Keywords: Helicobacter pylori, ethnomedicine, gastritis, natural products, peptic ulcer disease.
Abstract: The discovery of Helicobacter pylori (H. pylori), the curved or spiral shaped bacteria, as the main etiologic organism of chronic gastritis, peptic ulcer disease, and gastric cancer was one the most significant discoveries in gastroenterology of the twentieth century. Helicobacter infections promote infiltration of the gastric mucosa by neutrophils, macrophages, and T and B lymphocytes, and leaves the host prone to complications resulting from chronic inflammation. If left untreated, persistent gastrointestinal infections and chronic gastritis may evolve into more severe diseases, such as peptic ulcer or atrophic gastritis. In addition, infection with H. pylori increases the risk of developing gastric adenocarcinoma and mucosa-associated lymphoid tissue lymphoma. Helicobacter pylori infections are of great concern worldwide due to increasing antimicrobial resistance and high re-infection rates. In the 1990’s scientific evaluation of natural products and ethnomedicines for the treatment of H. pylori infections began in earnest, and many natural products have been investigated over the past 20 years with promising in vitro results. This review highlights these achievements and the classes of naturally occurring compounds with activity against H. pylori. It also points out the critical need of new treatments for H. pylori infections due to increasing global resistance.
Export Options
About this article
Cite this article as:
Lawal O. Temitope, Soni K. Kapil, Doyle J. Brian, Adeniyi A. Bolanle and Mahady B. Gail, Susceptibility of Helicobacter pylori to Natural Products: Can Past Research Direct Future Drug Development?, Current Bioactive Compounds 2012; 8 (3) . https://dx.doi.org/10.2174/157340712802762447
DOI https://dx.doi.org/10.2174/157340712802762447 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
SIRT1 as a Novel Potential Treatment Target for Vascular Aging and Age-Related Vascular Diseases
Current Molecular Medicine Tenofovir-Related Nephropathies in HIV-Infected Patients
Current Vascular Pharmacology Omega-3 Polyunsaturated Fatty Acids: Their Potential Role in Blood Pressure Prevention and Management
Current Vascular Pharmacology Serum Collagen Markers and Heart Failure
Cardiovascular & Hematological Disorders-Drug Targets Editorial (Thematic Issue: ‘Lone’ Atrial Fibrillation: No Longer Lone or Even Alone)
Current Pharmaceutical Design Fast Food Versus Slow Food and Hypertension Control
Current Hypertension Reviews Cardiac Toxicities of Antiangiogenic Therapies
Current Angiogenesis (Discontinued) Atrial Natriuretic Peptide: Structure, Function, and Physiological Effects: A Narrative Review
Current Cardiology Reviews High-Density Lipoprotein-Mediated Anti-Atherosclerotic and Endothelial-Protective Effects: A Potential Novel Therapeutic Target in Cardiovascular Disease
Current Pharmaceutical Design Experimental Rodent Models of Vascular Dementia: A Systematic Review
CNS & Neurological Disorders - Drug Targets When Cells Become a Drug. Endothelial Progenitor Cells for Cardiovascular Therapy: Aims and Reality
Recent Patents on Cardiovascular Drug Discovery Nutrition and Physical Activity on Hypertension: Implication of Current Evidence and Guidelines
Current Hypertension Reviews G-Lymphatic, Vascular and Immune Pathways for Aβ Clearance Cascade and Therapeutic Targets For Alzheimer’s Disease
Combinatorial Chemistry & High Throughput Screening Free Radicals and Antioxidants: How to Reestablish Redox Homeostasis in Chronic Diseases?
Current Medicinal Chemistry Understanding the Molecular and Cellular Changes Behind Aortic Valve Stenosis
Current Pharmaceutical Biotechnology Bilirubin Chemistry and Metabolism; Harmful and Protective Aspects
Current Pharmaceutical Design C-11 Radiochemistry in Cancer Imaging Applications
Current Topics in Medicinal Chemistry Molecular Modeling Investigation of Folic Acid Conjugation to MDM2 Inhibitors for Enhanced Cellular Uptake and Target Binding
Current Computer-Aided Drug Design Pindolol Augmentation of Antidepressant Response
Current Drug Targets Brain Aging in African-Americans: The Atherosclerosis Risk in Communities (ARIC) Experience
Current Alzheimer Research